1. Home
  2. CLCO vs PACB Comparison

CLCO vs PACB Comparison

Compare CLCO & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLCO
  • PACB
  • Stock Information
  • Founded
  • CLCO 2018
  • PACB 2000
  • Country
  • CLCO United Kingdom
  • PACB United States
  • Employees
  • CLCO N/A
  • PACB N/A
  • Industry
  • CLCO
  • PACB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CLCO
  • PACB Industrials
  • Exchange
  • CLCO Nasdaq
  • PACB Nasdaq
  • Market Cap
  • CLCO N/A
  • PACB 364.2M
  • IPO Year
  • CLCO N/A
  • PACB 2010
  • Fundamental
  • Price
  • CLCO $5.46
  • PACB $1.18
  • Analyst Decision
  • CLCO
  • PACB Buy
  • Analyst Count
  • CLCO 0
  • PACB 13
  • Target Price
  • CLCO N/A
  • PACB $2.46
  • AVG Volume (30 Days)
  • CLCO 312.9K
  • PACB 8.7M
  • Earning Date
  • CLCO 05-21-2025
  • PACB 05-08-2025
  • Dividend Yield
  • CLCO 10.98%
  • PACB N/A
  • EPS Growth
  • CLCO N/A
  • PACB N/A
  • EPS
  • CLCO 1.83
  • PACB N/A
  • Revenue
  • CLCO $322,510,000.00
  • PACB $154,014,000.00
  • Revenue This Year
  • CLCO $2.52
  • PACB $7.12
  • Revenue Next Year
  • CLCO N/A
  • PACB $26.83
  • P/E Ratio
  • CLCO $2.99
  • PACB N/A
  • Revenue Growth
  • CLCO N/A
  • PACB N/A
  • 52 Week Low
  • CLCO $4.94
  • PACB $1.08
  • 52 Week High
  • CLCO $13.68
  • PACB $3.85
  • Technical
  • Relative Strength Index (RSI)
  • CLCO 35.26
  • PACB 38.57
  • Support Level
  • CLCO $5.33
  • PACB $1.22
  • Resistance Level
  • CLCO $5.59
  • PACB $1.36
  • Average True Range (ATR)
  • CLCO 0.21
  • PACB 0.09
  • MACD
  • CLCO 0.08
  • PACB 0.00
  • Stochastic Oscillator
  • CLCO 33.68
  • PACB 34.48

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Share on Social Networks: